Corneal wound healing is a complex process involving the integrated actions of various growth factors, cytokines and extracellular matrix produced by corneal cells and inflammatory cells. Connective tissue growth factor (CTGF) has been linked to wound healing, and fibronectin (FN) is a major component of the extracellular matrix. However, the functions of CTGF and FN in corneal epithelial cells are not well understood. We therefore investigated the coordinated function of CTGF and FN in the attachment and migration of corneal epithelial cells. Treatment of human corneal epithelial cells (HCECs) with transforming growth factor (TGF) β 1 up-regulated the expression of CTGF, but did not noticeably affect FN expression, as judged by immunoblot analysis of cell lysates. In contrast, the amount of FN accumulated in the cultured media was increased in a time-dependent manner, but CTGF was undetectable in the cultured media. The expression level of FN was decreased by the knockdown of CTGF expression with a specific short hairpin RNA, indicating that CTGF acts as an upstream mediator of FN expression. CTGF augmented the FN-mediated increase in the attachment of HCEC by about twofold, although CTGF alone did not influence the attachment. Moreover, the migration assay with rabbit corneal blocks revealed that CTGF (390 nM) alone or in combination of FN (10 µ g/mL) promoted corneal epithelial migration; the mean migration distances of control, CTGF, and CTGF + FN were 272, 325, and 626, µ m, respectively. In conclusion, CTGF cooperates with FN in enhancing the attachment and migration of corneal epithelial cells.
The cornea is directly challenged to the exterior environments. Therefore, corneal epithelium plays a pivotal role as a barrier to keep the integrity of the ocular surface. When epithelial defects occur on the cornea, rapid re-epithelialization is critical in order to prevent invasion of pathogens into the corneal stroma. The corneal epithelium maintains its homeostasis and physiological characteristics by repeating a cycle of proliferation, migration and surficial cell loss (Thoft and Friend 1983) . Smooth corneal epithelial cell migration plays a central role in corneal epithelial wound healing; various growth factors, cytokines and extracellular matrices are all necessary for this cell migration (Wilson et al. 1992; Li and Tseng 1995) . Furthermore, stromal-epithelial interactions occur during corneal wound healing (Wilson et al. 1999 ) and activated keratocytes undergo myofibroblastic transformation (Jester et al. 1995; Funderburgh et al. 2003) .
Connective tissue growth factor (CTGF) is a downstream mediator of transforming growth factor (TGF)-β and is found in abundance in the lacrimal fluid (Grotendorst 1997) . CTGF is thought to play a role in maintenance of fibrosis (Bradham et al. 1991) . It was reported that CTGF expression is increased in fibrotic diseases of the lung (Allen et al. 1999) , kidney (Ito et al. 1998) , and skin (Igarashi et al. 1995) ; this mediator may be involved in the storage of the extracellular matrix. CTGF also exerts effects on cell attachment and migration (Fan et al. 2000) . In the cornea, CTGF promotes transdifferentiation of the corneal fibroblast into the myofibroblast, resulting in excess production of collagen and fibronectin (FN). CTGF is also involved in the wound healing process of the corneal stroma (Folger et al. 2001; Blalock et al. 2003; Garrett et al. 2004) . One of the reasons why CTGF has so many functions may be due to its binding to other cytokines and the extracellular matrix to modulate their actions (Frazier et al. 1996) . We reported that CTGF binds to FN (Yoshida and Munakata 2007) . Although the action of CTGF on the corneal epithelium is not well known, it has been shown that FN promotes corneal epithelial cell migration in culture (Watanabe et al. 1987) as well as in vivo (Nishida et al. 1983b) . Therefore, we examined the role of CTGF in corneal epithelial wound healing using cultured corneal epithelial cells and focusing on the interaction between FN and CTGF. We also used an organ culture method to investigate corneal epithelial cell migration.
Materials and Methods

Cell Culture
A human corneal epithelial cell (HCEC) line established using a simian virus 40 (SV40)-adenovirus recombinant vector was kindly provided by K. Araki-Sasaki. The cells were maintained in Dulbecco's modified Eagle's medium (DMEM)/F12 (1:1) (Gibco; Grand Island, NY, USA) containing 10% fetal bovine serum (FBS) (Gibco) at 37°C under humidified 5% CO 2 and 95% air.
Animals
Female albino rabbits weighting 2 to 3 kg were obtained from Hokusetsu Sangyo (Settsu, Osaka, Japan). This study was performed in compliance with the Rules and Regulations of the Animal Care and Use Committee, Kinki University School of Medicine, and followed the Guide for the Care and Use of Laboratory Animals, Kinki University School of Medicine.
Proteins
Human plasma fibronectin was purchased from Sigma-Aldrich (St. Louis, MO, USA). TGF-β 1 was purchased from R & D Systems (Minneapolis, MN, USA). The recombinant His-tagged human CTGF was purchased from Biovendor Laboratory Medicine, Inc. (Brno, Czech Republic).
Antibodies
The goat anti-human CTGF polyclonal antibody was purchased from R & D Systems. The rabbit anti-human FN polyclonal antibody and anti-human β -actin monoclonal antibody were purchased from Sigma-Aldrich. Horseradish peroxidase-conjugated donkey anti-rabbit and sheep anti-mouse IgG antibodies were purchased from GE Healthcare Bio-Sciences (Piscataway, NJ, USA). Horseradish peroxidase-conjugated rabbit anti-goat IgG antiboby was purchased from MBL (Nagoya, Japan). For the cell attachment assay, the mouse IgG anti-human FN was purchased from Takara Bio Inc. (Shiga, Japan) and normal mouse IgG was purchased from Sigma-Aldrich.
Plasmids and Transfection
Four independent short hairpin RNA (shRNA) constructs which were targeting four different exons of CTGF and one control plasmid were purchased from SABiosciences Corporation (Frederick, MD, USA). The sequences included CTGFshRNA1:5´-CCA GAC CCA-ACT ATGATTAGA-3´; CTGFshRNA2:5´-AGA CAT ACC GAG CTA-AATTCT-3´; CTGFshRNA3:5´-TAC CGA CTG GAA GAC ACG-TTT-3´; CTGFshRNA4:5´-TGACCTGGAAGAGAACATTAA-3´; and shRNA:5´-TGACCTGGAAGAGAACATTAA-3´ (negative control). HCECs were transfected with CTGFshRNA and control plasmids using lipofectamine 2000 transfection reagent (Invitrogen; Carsbad, CA, USA) following the manufacturer's instructions.
Briefly, HCEC-coated 12-well plates were grown to 95% confluence. Four microliters of lipofectamine 2000 regent was diluted in 96 µ L Opti-MEM medium (Invitrogen) and then mixed with 100 µ L Opti-MEM which included 1.6 µ g of shRNA plasmids. After incubating at 37°C for 4 hours, the medium was changed to DMEM containing 10% FBS and the plates were incubated for 48 hours under the same conditions.
Immunoblot Analysis
To examine the effects on CTGF and FN expression in HCECs by stimulating TGF-β 1, HCECs were cultured in DMEM containing 10% FBS. Prior to stimulation, cells were rendered quiescent by being maintained in serum-starved conditions for 24 hours. They were subsequently treated with 10 ng/mL of TGF-β 1 for up to 72 hours. Mean TGF-β 1 concentration in tear fluid is approximately 10-20 ng/mL (Gupta et al. 1996) ; therefore, TGF-β 1 concentration of 10 ng/mL was used in this experiment. The cell lysates and the conditioned media were collected at 0, 12, 24, 48, and 72 hours after TGF-β 1 stimulation. To investigate the role of CTGF in FN expression, HCECs transfected with CTGFshRNA were prepared as stated above. Cell lysates were prepared as described previously (Yoshida and Munakata 2007) . The lysates were examined by Western blot using antibodies against polyclonal goat anti-human CTGF, polyclonal rabbit anti-human FN, monoclonal anti-β -actin and peroxidaselinked secondary antibodies. The immunoblotted membrane was developed using an enzyme-linked chemiluminescence (ECL) kit (GE Healthcare Bio-Sciences) according to the manufacturer's instructions.
Cell Attachment Assay
Two experiments were performed to examine the interaction between CTGF and FN. In the first experiment, 1% bovine serum albumin (BSA) (Roche Diagnostics, Switzerland), CTGF, FN or CTGF+FN were added to the media and incubated for 2 hours. After the 2-hour incubation, HCECs in the wells (1,000 cells/well) were incubated in the treated media at 37°C for 45 minutes. In the second experiment, 100 µ L of HCEC suspension (1,000 cells/well) was placed in plates with FN-coated or uncoated wells. CTGF, CTGF + goat IgG anti-human FN, CTGF + normal goat IgG or 1% BSA , 1% BSA + mouse IgG anti-human FN, or 1% BSA + normal mouse IgG were added to the medium to investigate FN-dependant mechanisms. The cells were fixed and stained with 1% crystal violet in 95% ethanol, and the attached cells were counted under a phase-contrast microscope. Quadruplicate samples per treatment were tested and their mean average was obtained. Data were expressed as mean ± standard error of the mean (SEM) of the number of attached cells/well in three independent experiments.
Corneal Epithelial Migration Assay
The distance of rabbit corneal epithelial cell migration in culture was measured by a previously described method (Nishida et al. 1983a) . Briefly, rabbits were anesthetized with an intravenous injection of sodium pentobarbital (25 mg/kg body weight) and both eyes were enucleated. The sclerocorneal rim was excised, and the corneas were removed and then cut into small blocks with a razor blade. Six blocks (approximately 2 mm × 4 mm) were obtained from each cornea. The blocks were placed in 24-well culture plates and incubated for 24 hours in the medium containing either 1) CTGF at concentrations of 0, 390 nM or 3.9 µ M, or 2) CTGF at the same concentration plus FN (10 µ g/mL). Multiple blocks from the same cornea were used in each experiment. The blocks were paraffin-embedded. Four thin sections (3 µ m thick) were cut at 200 µ m intervals from each block and stained using hematoxylin-eosin. The length of the path of epithelial migration down both sides of each section was measured on the micrographs. Results obtained from the four sections of each side of each block were averaged as one measurement. Each value is the average ± SEM in three independent experiments.
Statistical Analysis
Statistical comparisons between two groups were performed by unpaired Student's t-test. ANOVA was used to compare three or more conditions with post hoc comparisons using the Tukey-Kramer procedure; p values < 0.05 were considered significant. Significant differences between groups are noted by *, † and ‡. Single symbol stands for p < 0.05, two symbols, for p < 0.01.
Results
Effects of TGF-β 1 on expression of CTGF and FN in HCECs
TGF-β 1 is known as a potent stimulator for connective tissue formation during wound repair and abundantly present in human tear fluid. It is also known that TGF-β 1 regulates CTGF expression and stimulates FN synthesis. Therefore, we examined whether the addition of TGF-β 1 promotes the expression levels of CTGF and FN in HCECs. The expression levels of CTGF and FN were analyzed in HCECs treated with TGF-β 1 by Western blotting. As shown in Fig. 1 , treatment with TGF-β 1 up-regulated CTGF expression at 48 and 72 hours, but did not affect FN expression at any time point up to 72 hours in cell lysates. Western blot analysis of the conditioned media was used to characterize CTGF and FN released to the conditioned medium. The amount of FN accumulated in the cultured media was increased in a time-dependent manner ( Fig. 1) , but we could not detect CTGF in the cultured media at any time point up to 72 hours (data not shown).
Suppression of FN expression with knockdown of CTGF expression
Because CTGF is involved in wound healing and fibrosis, CTGF may play a role in FN synthesis. To test this hypothesis, CTGF-specific shRNAs were introduced into HCECs and their effects on the expression of CTGF and FN were examined. As shown in Fig. 2 , CTGF-specific shR-NA1 and shRNA2 suppressed CTGF and FN expression in HCECs. The negative control of shRNA and lipofectamine 2000 solution had no inhibitory effects on either CTGF or FN production. CTGF-specific shRNA3 and shRNA4 had weak inhibitory effects on the expression of CTGF and FN compared with shRNA1 and shRNA2.
Cell Attachment Assay
Although FN (10 µ g/mL) itself facilitated the HCEC attachment to wells much more than control (1% BSA), CTGF significantly increased the number of HCECs attached in the presence of FN in the conditioned media compared with FN alone. However, CTGF alone had little effect on cell attachment (Fig. 3 ). There were no significant differences in the number of attachment cells between the CTGF concentration of 1.3 µ M and 3.9 µ M.
To further characterize the interaction between the CTGF and FN, FN-coated wells were prepared and the effects of CTGF, BSA or anti-FN antibody on cell attachment were examined. The media containing CTGF significantly promoted the attachment of HCECs compared with control (BSA), whereas anti-FN antibody completely inhibited CTGF-stimulated cellular adhesion to FN in comparison with control (IgG antibody) (Fig. 4) . These results suggest that CTGF-stimulated cellular adhesion would be a FN-dependant pathway.
The Effect of CTGF in the Presence or Absence of FN on Corneal Epithelial Cell Migration
Epithelial cell migration over cultured corneal blocks showed that CTGF alone stimulated epithelial cell migration in a dose-dependent manner (Fig. 5) . Mean values of control, CTGF (390 nM), CTGF (390 nM) + FN, and CTGF (3.9 µ M) were 272, 325, 626, and 720 µ m, respectively. CTGF (390 nM) plus FN (10 µ g/mL) promoted significantly greater epithelial cell migration compared to CTGF alone (Fig. 5) . When the CTGF concentration in the media was 3.9 µ M, no significant difference in migration distance was seen between CTGF plus FN and CTGF alone (Fig. 5) .
Discussion
This report documents the interaction between CTGF and FN in corneal epithelial adhesion and cell migration. Little is known about the effects of CTGF on corneal epithelial cells. Recently, Secker et al. (2008) demonstrated that CTGF regulates corneal re-epithelialization stimulated by TGF-β 1. Our results concur with their report that CTGF promotes corneal epithelial migration and expand on their findings by demonstrating that CTGF promoted corneal epithelial cell adhesion and migration in the presence of FN, even in the absence of TGF-β 1.
To the best of our knowledge, there are no reports where protein level fluctuation of FN stimulated by TGF-β 1 in cultured human corneal epithelial cells was investigated, although there are many papers reporting that TGF-β 1 stimulates an increase in the expression of FN in the corneal fibroblasts (Ohji et al. 1993; Sharma et al. 2009 ). As shown in Fig. 1 , TGF-β 1 promoted CTGF expression, but did not affect FN production in the cell lysates. However, Western blot analysis of the conditioned media from HCECs treated with TGF-β 1 showed that the amount of FN released by HCECs were increased in a time-dependent manner. This is probably that FN is constitutively expressed in the corneal epithelial cells and the accumulation of secreted FN was increased in the media. On the other hand, CTGF could be detected in the cell lysates, while could not be detected in the supernatant of the cultured media (Fig. 1) . This is prob-ably because the amount of secreted CTGF was too minute to be detected. The coordination between CTGF and FN expression in cell lysates and media was not observed. One interpretation for these results is FN may be secreted into the media much more than CTGF. Further study is required to clarify the precise mechanism of the phenomena. HCECs were incubated with 10 ng/mL of TGF-β 1. At the indicated time, cells were recovered and lysed. The cell lysates and conditioned media were separated in a polyacrylamide gel. After SDS-PAGE, the proteins were transferred onto PVDF membrane, and probed with anti-FN, CTGF or β -actin antibody. β -actin was used as a loading control. Secondly, we synthesized four CTGF-specific shRNAs and transfected them into corneal epithelial cells to examine their effects on the expression of CTGF and FN. Western blot analysis showed that two of the four constructed shRNAs strongly inhibited CTGF protein production, but the other shRNAs had weak inhibitory effects. The reason for the different results observed with these shRNAs might be due to a position effect. In the present study, the transfected cells which suppressed CTGF production also inhibited FN production and CTGF clearly regulated the expression of FN as shown in Fig. 2 . Therefore, we suspect that FN functions downstream of CTGF.
Based on the results of our cell attachment assay, we indicated that CTGF bound to FN would have synergistic effects in promoting corneal epithelial cell adhesion. To our knowledge, there is no report which has investigated the adhesive function of CTGF to corneal epithelial cells, although there are some reports that demonstrated that CTGF enhanced cell adhesion of other types of cells to FN (such as stellate cells, sinusoidal endothelial cells, and chondrocytes) (Hoshijima et al. 2006; Pi et al. 2008) .
Moreover, in our organ culture model, we have demonstrated that the interaction of CTGF and FN promoted corneal epithelial migration significantly when compared to FN alone at the CTGF concentration of 390 nM. However, CTGF (at 3.9 µ M) alone had almost the same level of corneal epithelial migration promotion as did a combination of CTGF and FN. As to this fact, we propose that at the concentration of 3.9 µ M, even with CTGF alone, the maximum corneal epithelial migration was achieved; however, it is possible that other factors besides FN are involved in promotion of CTGF-induced corneal epithelial cell migration.
The present study is limited to in vitro and organ culture experiments, with no in vivo investigations. In vivo, TGF-β 1 is abundantly present on the surface of the eye, as are other factors suppressing CTGF, which leads to more complex regulation of CTGF. The results of our cell attachment assay showed no effects on cell attachment with CTGF alone, and the effect of CTGF on the cell attachment was FN-dependent. In the organ culture model, however, the 3.9 µ M concentration of CTGF alone promoted migration of corneal epithelial cells independent of FN.
Our study has an advantage in that we have proven coordination of CTGF and FN in the adhesion and migration of corneal epithelial cells. We anticipate that we may be able to apply our results clinically by controlling CTGF, Corneal blocks were cultured for 24 hours with various concentrations of CTGF either with or without FN (10 µ g/mL). The length of the path of epithelial migration was measured on the micrographs. With the concentration of CTGF at 390 nM, CTGF plus FN significantly promoted epithelial cell migration than CTGF alone. However, the 3.9 µ M concentration of CTGF alone promoted migration of corneal epithelial cells without the presence of FN. Each value is the average ± SEM in three independent experiments (*p < 0.05).
which has a close relationship with TGF-β 1 and FN, for treatment of some intractable corneal epithelial diseases.
